Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02297438
PHASE3

A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]

Sponsor: Pfizer

View on ClinicalTrials.gov

Summary

The study is designed to compare the clinical benefit following treatment with letrozole in combination with Palbociclib versus letrozole in combination with placebo in Asian postmenopausal women with ER(+)/HER2(-) advanced breast cancer who have not received prior systemic anti cancer therapies for their advanced/metastatic disease.

Official title: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDY OF PALBOCICLIB (ORAL CDK 4/6 INHIBITOR) PLUS LETROZOLE VERSUS PLACEBO PLUS LETROZOLE FOR THE TREATMENT OF PREVIOUSLY UNTREATED ASIAN POSTMENOPAUSAL WOMEN WITH ER (+), HER2 (-) ADVANCED BREAST CANCER

Key Details

Gender

FEMALE

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

340

Start Date

2015-03-23

Completion Date

2025-02-24

Last Updated

2026-05-14

Healthy Volunteers

No

Interventions

DRUG

Palbociclib

Palbociclib, 125mg, orally once daily on Day 1 to Day 21 of every 28-day cycle followed by 7 days off treatment

DRUG

Letrozole

Letrozole, 2.5mg, orally once daily (continuously)

DRUG

Placebo

Placebo, 125mg, orally once daily on Day 1 to Day 21 of every 28-day cycle followed by 7 days off treatment

DRUG

Letrozole

Letrozole, 2.5mg, orally once daily (continuously)

Locations (54)

The First Affiliated Hospital of Bengbu Medical College/Medical Oncology Department

Bengbu, Anhui, China

The First Affiliated Hospital of Anhui Medical University

Hefei, Anhui, China

Fujian Medical University Union Hospital/Medical Oncology Department

Fuzhou, Fujian, China

Sun Yat-Sen University Cancer Center

Guangzhou, Guangdong, China

Zhongshan Ophthalmic Center,Sun Yat-Sen University

Guangzhou, Guangdong, China

Breast Tumor Center, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Guangzhou, Guangdong, China

Guangdong Provincial People's Hospital

Guangzhou, Guangdong, China

Fourth Hospital of Hebei Medical University

Shijiazhuang, Hebei, China

Harbin Medical University Cancer Hospital/Oncology Department

Harbin, Heilongjiang, China

Henan Cancer Hospital

Zhengzhou, Henan, China

Hubei Cancer Hospital

Wuhan, Hubei, China

The Second Xiangya Hospital of Central South University

Changsha, Hunan, China

Hunan Provincial Tumor Hospital/Breast Internal Medicine Department

Changsha, Hunan, China

Jiangsu Cancer Hospital

Nanjing, Jiangsu, China

Jiangsu Province Hospital

Nanjing, Jiangsu, China

The First Hospital of Jilin University

Changchun, Jilin, China

Jilin Provincial Cancer Hospital

Changchun, Jilin, China

The First Hospital of China Medical University/Oncology Department

Shenyang, Liaoning, China

Liaoning Province Cancer Hospital

Shenyang, Liaoning, China

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China

West China Hospital of Sichuan University

Chengdu, Sichuan, China

Tianjin Cancer Hospital/Breast cancer department

Tianjin, Tianjin Municipality, China

The Tumor Hospital of Yunnan Province

Kunming, Yunnan, China

The First Affiliated Hospital of College of Medicine, Zhejiang University

Hangzhou, Zhejiang, China

Sir Run Run Shaw Hospital of College of Medicine of Zhejiang University, Center for Oncology

Hangzhou, Zhejiang, China

Zhejiang Cancer Hospital

Hangzhou, Zhejiang, China

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Beijing, China

307 Hospital of PLA

Beijing, China

Beijing Cancer Hospital

Beijing, China

Peking University Third Hospital/Department of Oncology

Beijing, China

Chinese PLA General Hospital/Oncology

Beijing, China

Oncology Department, the Second Affiliated Hospital of Third Military Medical University, PLA

Chongqing, China

Fudan University Shanghai Cancer Center

Shanghai, China

Department of Clinical Oncology

Hong Kong, Hong Kong

Queen Mary Hospital

Hong Kong, Hong Kong

Raffles Cancer Centre

Singapore, Singapore

Parkway Cancer Centre

Singapore, Singapore

Tan Tock Seng Hospital

Singapore, Singapore

Tan Tock Seng Hospital

Singapore, Singapore

China Medical University Hospital

Taichung, Taiwan

National Cheng Kung University Hospital / Internal Medicine

Tainan, Taiwan

National Taiwan University Hospital

Taipei, Taiwan

Mackay Memorial Hospital

Taipei, Taiwan

Taipei Medical University Hospital/ Department of Surgery

Taipei, Taiwan

Taipei Veterans General Hospital/Surgery Department

Taipei, Taiwan

Koo Foundation, Sun Yat-Sen Cancer Center

Taipei, Taiwan

Taipei Municipal Wanfang Hospital (Managed by Taipei Medical University )

Taipei, Taiwan

King Chulalongkorn Memorial Hospital

Pathumwan, Bangkok, Thailand

Chula Clinical Research Center (Chula CRC)

Patumwan, Bangkok, Thailand

Department of Medicine, Faculty of Medicine, Naresuan University

Muang, Changwat Phitsanulok, Thailand

Division of Therapeutic Radiology and Oncology, Department of Radiology

Muang, Chiang Mai, Thailand

Ramathibodi Hospital, Mahidol University

Bangkok, Ratchathevi, Thailand

Oncology Unit, Department of Internal Medicine, Phramongkutklao Hospital

Bangkok, Thailand

Division of Medical Oncology, Department of Medicine,

Bangkok, Thailand